| Thursday February 05, 2026 | |
| 10:00 – 15:00 | Registration |
| Opening Ceremony | |
| 15:00 – 15:15 | Prof. Dr. Serdar BURMAOĞLU, Chair |
| 15:15 – 15:30 | İkram CENGİZ, Chair of The Turkish Chemists` Society |
| 15:30 – 15:45 | Doğan TAŞKENT, ATABAY İlaç, Strategy and R&D Director |
| 15:45 – 16:00 | Assoc. Prof. Dr. Esen BELLUR ATİCİ, DEVA Holding A.Ş., R&D and Clinical Development Director |
| 16:00 – 16:15 | Prof. Dr. Ahmet AYAR, TITCK, President |
| 16:15 – 16:30 | Prof. Dr. Ahmet HACIMÜFTÜOĞLU, Atatürk University, Rector |
| 16:30 – 16:45 | Sağlık Bakanlığı |
| 16:45 – 18:00 | Panel “Bilim Odaklı Üreten Sağlık: Hammaddeden İlaca” “Science-Driven Healthcare: From Raw Materials to Medicine” |
| 18:00 – 19:00 | Crystal Mortar Awards Ceremony & Congress Photograph |
| Friday February 06, 2026 | |
| Session 1 | Session Chair: Assoc. Prof. İrem Kulu |
| 09:00 – 09:40 | Prof. Dr. Stefan LAUFER, Tuebingen University, Germany Discovery and Development of A First in Class MKK-4 Inhibitors to Increase Liver Regeneration |
| 09:40 – 10:10 | Prof. Dr. Mustafa SOYLAK, Erciyes University, Türkiye Green Microextraction Methodologies in the Analysis of Drug Content of Wastewater and Biological Samples |
| 10:10 – 10:30 | Prof. Dr. Ayhan ORAL, Çanakkale Onsekiz Mart University, Türkiye Pharmaceutical Release Control through Biopolymeric Matrix Systems |
| 10:30 – 11:00 | Coffee Break |
| Session 2 | Session Chair: Prof. Dr. Stefan LAUFER |
| 11:00 – 11:40 | Prof. Dr. Nathaniel I. MARTIN, Leiden University, Netherlands A Potent Next-Generation Glycopeptide with Best-In-Class Potential |
| 11:40 – 12:10 | Dr. Pedro HURTADO, Anton Paar, Austria Innovative Approaches to Pharmaceutical QA/QC and R&D Using X-Ray Analytics Technologies |
| 12:10 – 12:30 | Azim Ziyaei HALIMEHJANI, Sharif University of Technology, Iran In Situ Prepared Dithiocarbamic Acids in Click Thiol-Ene and Thiol-Yne Reactions |
| 12:30 – 14:00 | Lunch |
| Session 3 | Session Chair: Prof. Dr. Nathaniel I. MARTIN |
| 14:00 – 14:40 | Prof. Dr. Fernando ALBERICIO, University of KwaZulu-Natal and Universiy of Barcelona, Spain The Peptide Golden Era: Challenges and Opportunities Ahead |
| 14:40 – 15:10 | Prof. Dr. Engin ULUKAYA, İstinye University, Türkiye DLD-6, a Novel Naphthoquinone-Derived Compound, as a Promising Anticancer Candidate for Cholangiocarcinoma |
| 15:10 – 15:30 | Assoc. Prof. Dr. Safacan KOLEMEN, Koç University, Türkiye Dual-Mode Type-I/II Photosensitizers for Treatment of Cancer Cells and Bacterial Infections |
| 15:30 – 16:00 | Coffee Break |
| Session 4 | Session Chair: Prof. Dr. Fernando ALBERICIO |
| 16:00 – 16:40 | Prof. Dr. Andrew WESTWELL, Cardiff University, UK The Discovery and Preclinical Development of Anticancer BCL-3 Inhibitors |
| 16:40 – 17:10 | Prof. Derya İLEM ÖZDEMİR, Ege University,Türkiye Current Strategies and Targeting Approaches in the Development of Next-Generation Radiopharmaceuticals |
| 17:10 – 17:25 | Melisa TECİK, Abdullah Gül University, Türkiye LGALS3 (Galectin-3), a Methylation-Regulated Differentially Expressed Gene, as a Therapeutic Candidate in Midostaurin-Resistant FLT3-ITD Positive Acute Myeloid Leukemia |
| 17:25 – 17:40 | Nurten UÇAK, Metrohm, Türkiye Titration for Pharmaceutical Analysis |
| 17:40 – 17:55 | SRK Raju SAGIRAJU, Abdi İbrahim, Türkiye Strategıc Formulatıon Development of a Hıghly Varıable Antıvıral Drug Product Wıth Novel Salt / Novel Morph From Solubility Limitations to Bioequivalence Achievement |
| 17:55 – 18:10 | Ceylin ÖKTEN, Gen İlaç, Türkiye Cleaning Test Analytical Method Validation for the Determination of Hydrocortisone Residues in Hydrocortisone MR Tablet Manufacturing |
| Session 5 | Short Oral Presentations |
| Main Hall ve Antalya I | |
| 18:15 – 19:00 | Session Chair: Prof. Dr. Engin ULUKAYA Session Chair: Prof. Dr. Derya İLEM ÖZDEMİR Session Chair: Assoc. Prof. Dr. Safacan KOLEMEN Session Chair: Prof. Dr. Ayhan ORAL |
| 19:00 – 20:30 | Dinner |
| 20:30 – 22:00 | Poster Presentations, Main Hall |
| Saturday February 07, 2026 | |
| Session 6 | Session Chair: Prof. Dr. Mustafa SOYLAK |
| 09:00 – 09:40 | Assoc. Prof. Dr. Sandra GEMMA, University of Siena, Italy Targeting Parasite Redox Homeostasis: Efficiency, Selectivity, and Therapeutic Promise |
| 09:40 – 10:10 | Prof. Dr. Erden BANOĞLU, Gazi University, Türkiye Inhibiting Transforming Acidic Coiled-Coil Protein 3 (TACC3): A New Modality for Targeted Cancer Therapy |
| 10:10 – 10:30 | Prof. Dr. Yusuf DiLGiN, Çanakkale Onsekiz Mart University, Türkiye Sensitive and selective electrochemical determination of drugs used in the treatment of COVID19 |
| 10:30 – 11:00 | Coffee Break |
| Session 7 | Session Chair: Prof. Dr. Sandra GEMMA |
| 11:00 – 11:40 | Dr. Ketkee DESHMUKH, Gattefosse, India Unlocking the Potential of Lipid Solubilisers in Tablet for Enhancing Oral Bioavailability |
| 11:40 – 12:10 | Prof. Dr. Görkem GÜNBAŞ, METU, Türkiye Small Changes, Big Impact: Engineering the Xanthene Core for Photodynamic Therapy of Brain Cancers |
| 12:10 – 12:30 | Sıla Özlem ŞENER, University of Health Sciences, Türkiye The Natural Compound Oleuropein in Pulmonary Arterial Hypertension: TGF-β Pathway Modulation |
| 12:30 – 14:00 | Lunch |
| Session 8 | Session Chair: Prof. Dr. Erden BANOĞLU |
| 14:00 – 14:40 | Prof. Dr. Svetlana B. TSOGOEVA, Friedrich Alexander University, Germany Multi-Step Domino Reactions: Facile Access to New Antimalarial, Antiviral and Anticancer Agents |
| 14:40 – 15:00 | Raid ABDEL-JALIL, Sultan Qaboos University, Oman Design and Synthesis of Novel Benzimidazoles and Their Applications in Analytical Chemistry and Food Science |
| 15:00 – 15:15 | Gülay DİLEK, Bülent Ecevit University, Türkiye Synthesis and Theoretical Evaluation of a Selenium-Containing Hydroxyacetophenone Derivative as a Dual CysLT1/CysLT2 Antagonist for Neuroinflammation |
| 15:15 – 15:30 | Parsa SANAEI, Eskişehir Osmangazi University, Türkiye Synthesis and Biological Evaluation of Novel Human Acid Ceramidase Inhibitors |
| 15:30 – 16:00 | Coffee Break |
| Session 9 | Session Chair: Prof. Dr. Andrew WESTWELL |
| 16:00 – 16:40 | Prof. Dr. Jeroen S. DICKSCHAT, University of Bonn, Germany The Mysterious Case of Sodorifen and Beyond: Mechanistic Investigations on Terpene Synthases |
| 16:40 – 17:20 | Naiffer ROMERO, US Pharmacopeia, Maryland, USA Nitrosamines Impurities Landscape: What We Have Learned as We Prepare for the Future |
| 17:20 – 17:35 | Soner TURAN, Abdi İbrahim, Türkiye RP-HPLC Method Development and Validatıon for Separation of a Class II Anticancer Drug Product Related Substances Using a Quality by Design Approach Using Fusion Software |
| 17:35 – 17:50 | Nader Ghaffari KHALIGH, University of Malaya, Malaysia Study of Heterocyclic Substituent on Geometry and Biological Activity of Biguanidine Derivatives |
| 17:50 – 18:05 | Yasemin TORLAK, Pamukkale University, Türkiye Electrochemical Detection of Interaction Between Daunorubicin and DNA by Nanohybride Modified Electrodes |
| 18:25 – 20:30 | Dinner |
| 20:30 – 22:00 | Poster Presentations, Main Hall |
| Sunday February 08, 2026 | |
| Session 10 | Session Chair: Prof. Dr. Esen Bellur Atici |
| 09:00 – 09:40 | Prof. Dr. Fraser FLEMING, Drexel University, USA Research Problems We Never Talk About |
| 09:40 – 10:10 | Prof. Dr. Amitav SANYAL, Boğaziçi University, Türkiye Polymeric Soft Balls: Design of Nanomaterials to Address Challenges in Cancer Therapy |
| 10:10 – 10:25 | Firouz Matloubi MOGHADDAM, Sharif University of Technology, Iran Design of Novel Magnetic Nanocatalyst for Synthesis of Biological Scaffolds and Molecular Docking Studies |
| 10:25 – 10:40 | Afshan SIDDIQ, University of Karachi, Pakistan A Panoramic View on Ethanopharmacognostic Features, Phytochemical Constituents and Pharmacological Activities of the Ethanolic Extract of the Mixture of Cinnamomum tamala (leaves) and Trachyspermum ammi (seeds) |
| 10:40 – 10:55 | Sema ARISOY, Selçuk University, Türkiye Preliminary Study on Hyaluronic Acid–Glatiramer Acetate Nanoparticles |
| 10:55 – 11:10 | Yasemin ÇAĞLAR, Giresun University, Türkiye Application of a π-Extended Silicon Phthalocyanine Ligand in DLLME Coupled with UV–Vis Determination of Cr³⁺ Ions |
| 11:10 – 12:00 | Closing Ceremony and Poster Awards |
| Short Oral Presentation Program | ||
| Session 5 | ||
| Main Hall Session Chair: Prof. Dr. Engin ULUKAYA Session Chair: Prof. Dr. Derya İLEM ÖZDEMİR | ||
| Poster no | Author | Title |
| OP1 | Hacı Mehmet KAYILI | HPLC-HILIC-FLD Glycan Signatures with Machine Learning for Early-Stage NSCLC Detection |
| OP2 | Ayşe Hümeyra KAYMAZ | Design and Synthesis of Nitrogen-Containing Hybrid Compounds for EGFR Inhibition |
| OP3 | Havva Berre AYVAZ | A Novel Approach In Acute Myeloid Leukaemia Treatment by Combining Genetic and Epigenetic Candidate Drug Agents |
| OP4 | Eren CANER | Synthesis and Structure Elucidation of 5,7-Diarylsubstituted Triazolopyrimidine Derivatives and Their Anticancer Activities |
| OP5 | Durmuş AKDOĞAN | Highly Sensitive qPCR-based Method Development for Quantitation of Residual Host Cell DNA in Biopharmaceutical Samples |
| OP6 | Derya HATİPOĞLU | Comparative Forced Degradation Stability Assessment for Selecting a New Formulation for a Monoclonal Antibody |
| OP7 | Ramazan KOÇAK | Oxidation of Dihydropyridazines with Trichloroisocyanuric Acid (TCCA) |
| OP8 | Yağız GÜRBÜZER | Development of a High-Performance Liquid Chromatography Method for the Simultaneous Determination of Spiramycin and Metronidazole |
| OP9 | Muhammed Oğuzhan DOĞAN | Synthesis and Structure Elucidation of Some New Hydrazones Bearing Piperidine Ring and Their Derived Metal Complexes |
| OP10 | Setareh DORREH | Molecularly Imprinted Polymer-Based Voltametrıc Sensor For Tenoxicam: An Electrochemical Approach For Antiinflammatory Drug Detection |
| OP11 | Nurettin TOKAY | A Single-Capture SPR Strategy for Quantitative Analysis of Low-Affinity Fc Receptor–Antibody Interactions |
| OP12 | Mustafa Z. KAZANCIOGLU | Design and Synthesis of Urea–Tetrahydroquinoline Hybrid Molecules with Significant Biological Potential |
| OP13 | Ayşe Nur ARSLAN | Combinatorial Anticancer effect of Ethanolic Red Hawthorn Extract and Ethacrynic Acid both on Cholangiocarcinoma and Hepatocellular Carcinoma |
| OP14 | Melek KAYA | Synthesis and Bioactivity Assessment of Novel 2,3-Disubstituted Triazolopyrimidinone Derivatives Targeting NLRP3 Inflammasome Activation |
| OP15 | Hüseyin KOSKER | Synthesis, Structure Elucidation, Anticancer Activities of New 7- Arylmethylamino Triazolopyrimidine Derivatives |
| OP16 | Osman Nuri ASLAN | Synthesis, Characterization and Sensor Applications of a Novel Hydrazone Derivative Molecule |
| OP17 | Ceyhun SARI | A comprehensive in silico approach towards the discovery of Novel Anaplastic Lymphoma Kinase (ALK) Tyrosine Kinase Domain Inhibitors from a Large Natural Product Database |
| OP18 | Merve ÇELİK YAMACI | Analytical-Driven Surfactant Selection in Monoclonal Antibody Formulations: A Comparative LC-CAD Evaluation of Polysorbate 80 and Poloxamer 188 |
| OP19 | Selin BACAKCI | Investigation of the Inhibitory Potential of Astaxanthin on HIV-1 Reverse Transcriptase Using In Silico and In Vitro Approaches |
| OP20 | Sıla GÜLBAĞ PINAR | Development and Evaluation Of New Ibuprofen-Containing Suppository Formulations for Pediatric Purposes |
| OP21 | Şerife Ezgi ÇETİN | Design, Synthesis, and Bioactivity Evaluation of Antimicrobial 2-Substituted Thiazolopyrimidine Compounds |
| OP22 | Büşra UÇAR EKE | Metabolic Profiling of Active and Remission Ulcerative Colitis with Patients |
| OP23 | Ferruh LAFZİ | Ring opening of Donor-acceptor Cyclopropanes via Aminorhodanine |
| OP24 | Fatma BAYRAKÇEKEN NIŞANCI | Electrochemically Engineered C60–Retinol Nanostructured Electrodes: Redox Behavior and Biomedical Applications |
| Antalya I Session Chair: Assoc. Prof. Dr. Safacan KOLEMEN Session Chair: Prof. Dr. Ayhan ORAL | ||
| Poster no | Author | Title |
| OP25 | Şüheda ÖZKUL | The investigation of the effect of apricot kernel oil on human erythrocyte carbonic anhydrase isoenzymes (hCA I and hCA II) |
| OP26 | Betül ÇAYIR | Synthesis of New Quinoline-2(1H)-One Derivatives and Determination of Pharmacological Properties |
| OP27 | Dila KUMAS | A Novel Media Screening Strategy for Optimizing the Upstream Mammalian Cell Culture Process |
| OP28 | Duygu ENEŞ | Metabolic Alterations Induced by Momordica charantia L. Extracts in Melanoma Cells |
| OP29 | Jülide KAVUK | Synergistic Antiproliferative Effects of Cinnamic Acid and SYK Inhibition in Cholangiocarcinoma and Hepatocellular Carcinoma Cell Lines |
| OP30 | Melisa TECİK | A novel competing endogenous RNA network based on a RNA-seq reveals potential mechanisms and biomarkers of midostaurin resistance in FLT3-ITD AML |
| OP31 | Rüstem EBİRİ | Synthesis and Biological Activity Evaluation of Chalcone Conjugates Derived from Chiral and Achiral Amino Acids |
| OP32 | Vuslat Hazal ŞAHMETLİOĞLU | Investigation of Therapeutic Intervention of Green Synthesized Silver Zinc Oxide Nanoparticles with Usnea Lichen in the MOLM-13 Cell Line |
| OP33 | Türker DEVECİ | A Study of Dissolution Method Development and Validation for HMN-A1 and HMN-A2 Actıve Substances in Fixed-Dose Combination Tablet Product by HPLC |
| OP34 | Baran DİNGİLOĞLU | Comparative Evaluation of Membrane and Conventional Resin-Based Chromatography Purification in mAbdi2 Biosimilar Downstream Processing |
| OP35 | Oğuzhan DALKILIÇ | Regulatory-Ready LC-MS/MS Determination of Trace-Level N-Nitrosamines in Pharmaceutical Products |
| OP36 | Meryem KAPLAN | Development and In Vitro Characterization of a Soothing Stick Formulation for Dry and Pruritic Skin |
| OP37 | Büşra ÖZTÜRK AYDIN | Synthesis of N-Alkylated Pyrazolo[3,4-d]pyrimidine-Based Chalcone Hybrids |
| OP38 | Amine MUHCU | Experimental and In Silico Evaluation of Satureja spicigera Essential Oil as a Natural Acetylcholinesterase Inhibitor |
| OP39 | Amine Sümeyye KILINÇ | Identification and Characterization of Novel Peptides from Momordica charantia Seeds |
| OP40 | Özlem TUNCER | Synthesis, Characterization, and Determination of Anticancer Activities of Chalcone-Based Gold Nanoparticles |
| OP41 | Arzu GÖBEK | Design, Synthesis, and Evaluation of Novel Hybrid Compounds with Potential Antimicrobial Activity |
| OP42 | Arzu GÖBEK | Chalcone Derivatives as Effective Antibacterial Agents Against Acinetobacter baumannii |
| OP43 | Arzu GÖBEK | Synthesis and Antitubercular Evaluation of Novel Amide-Bridged Bis-Derivative Compounds |
| Poster Program | ||
| Main Hall | ||
| Poster no | Author | Title |
| P1 | Fatmanur KARAKAYA KARABUL | Determination of Compounds Related to The Molecule in The Capsule Dosage Form by High-Performance Liquid Chromatography (HPLC) |
| P2 | Alper ARABACI | Development of a Cyclosporine-Loaded Ophthalmic Micellar Formulation Using a Quality by Design (QbD) Approach |
| P3 | Miray BOMBOM | Development of a Tretinoin-Loaded Chitosan Patch Facial Mask Incorporating Rosmarinus officinalis for Acne Treatment |
| P4 | Ramazan ULUS | A New Simple Liquid Chromatographic Assay for Sodium Metabisulfite in Gentamicin Sulphate Injection Solution for Veterinary Use |
| P5 | Ayşe Zehra ÖZDEMİR | Project Management Approach in Pharmaceutical R&D: Time, Resource and Budget Management |
| P6 | Gizem MAĞILTAŞ | Measurement of Particle Size and Size Distribution in an Ophthalmic Eye Drop Containing Dexamethasone Using the Laser Light Diffraction Method |
| P7 | Hasan Yavuz GÖREN | Rigid Cyanine Design for Enhanced Fluorescence Quantum Yield in Near- Infrared Tumor Imaging |
| P8 | Sultan Cansel MEMİŞ | Pharmaceutical Development of Eltrombopag Olamine Tablet: Overcoming Stability, In Vitro Performance, and In Vivo Bioequivalence in an Orphan Drug |
| P9 | Sümeyye Nur ÇAKMAK | Development of Innovative Synthetic and Natural Source–Based Tissue Adhesives |
| P10 | Alper BALCI | Inhibition of Paraben Antimicrobial Activity by Nonionic Surfactants: A Case Study with Cetomacrogol 1000 |
| P11 | Esra ÖZER | Pain Management with a Topical Gel Formulation Containing Ilex paraguariensis and Mentha piperita Extracts |
| P12 | Dicle KARABAYIR | Risk-Based Cleaning Validation: An Applied Evaluation of Equipment and Manufacturing Area Hygiene |
| P13 | Erol AKIŞIK | Development of a Lyophilized Injectable Formulation Containing Folic Acid, Stability Studies, and Analytical Method Validation |
| P14 | Ezgi GÜNEŞ GÜRDAL | Development and validation of stability-indicating UHPLC methods for bortezomib injection solutions |
| P15 | Melike ÇELİK | Synthesis and structural elucidation of compounds containing quinazoline and biphenyl cores with potential biological activity |
| P16 | Resul ÜSTÜNBAŞ | Essential Similarity Study of Physicochemical Characteristics in Bioequivalence Assesments for Mufines 100 mg Lyophilized Powder for Solution for I.V. Infusion |
| P17 | Sıla ÇAM | Synthesis and Structural Elucidation of Compounds Containing Quinazoline and Biphenyl Cores with Potential Biological Activity |
| P18 | Murat IŞIK | Comparative Insights: How Stearic Acid and Polymer-Based Coatings Shape Tablet Stability |
| P19 | Melisa ÇETİN | Beyond the Basics: Advanced Patent Searching Strategies in Biologics |
| P20 | Feride AYVAZ TÜTÜNCÜ | Effects of N-Nitrosodimethylamine (NDMA) and N-Nitrosodiethylamine (NDEA) Genotoxic Impurities on Oxidative Stress |
| P21 | Aminesena BAŞER | Synthesis of Acetazolamide Targeted NTR Activated Chemiluminescent Probe for Hypoxic Tumor Detection |
| P22 | Ertuğrul İŞLEYEN | NDMA Analysis in Irbesartan-Containing Drugs Indicated for the Treatment of Hypertension |
| P23 | Zeynep ÇEBİŞLİ AHRAZOĞLU | Fampridine: The Bioequivalence Journey of a Prolonged-Release Drug |
| P24 | Müge MEMİŞ DAĞLI | Elucidation of The Impurity Structure in The Terminal Sterilized Intravenous Pharmaceutical Form of Sugammadex Sodium Using LC-HRMS Method |
| P25 | Salih DANACI | Clinical and Analytical Advantages of Dual-Release Combination Formulations: An Integrated Approach to Glycemic Control through IR/XR Systems |
| P26 | Büşra YONEY | Role of Different Petrolatum Sources on the Rheology of Ophthalmic Ointment |
| P27 | Aslıhan KILIÇ | In Silico Design of New Inhibitors for the Treatment of Osteoporosis |
| P28 | Feride DİNÇ | Evaluation of Sodium Metabisulfite Concentration Compatibility with Epinephrine and Its Influence on the Stability of Injectable Epinephrine Formulations |
| P29 | Aliye Beyza ÖZÇELİK | Synthetic Lethality Induced by Targeted WRN Protein Degradation in Microsatellite Instability Cancers |
| P30 | Okan AYKAÇ | Investigation of Bacterial and Human Topoisomerase I Inhibition Potential of Recalled Drugs by Molecular Docking Method and ADME Analyses |
| P31 | Sümeyye ZARF TOKAN | Extraction of Melatonin from Silver Linden (Tilia tomentosa Moench) Plant and with HPLC-UV Quantitative Determination |
| P32 | Asya Öykü TUĞRUL | Quality by Design (QbD): A Paradigm Shift in Pharmaceutical Development |
| P33 | Fatma ENGİN | Development of a Catheter Gel Containing Anesthetic and Antiseptic Active Ingredients |
| P34 | Hilal KARAPINAR | In Vitro Release Testing (IVRT) Evaluation of a Diclofenac Diethylammonium Topical Spray |
| P35 | Ilgım SOYSAL | Excipient Compatibility and Stability Assessment in XR Tablet |
| P36 | Aydan ÖZDEN | Pharmaceutical Chemistry–Based Strategies for Taste Masking of Paracetamol Suspensions |
| P37 | Seda AYGÖREN | Innovation, Commercialization, and Tax Advantages at The Intersection of R&D Centers and Patents |
| P38 | Caner KAYA | Design and Synthesis of Thymol–Indole Hybrid Derivatives |
| P39 | Emine YURTOĞLU | Comparison of EC and EW Formulations of Lambda-cyhalothrin |
| P40 | Feyza BOYLU | Development of Fatty Acid–Conjugated Tetrapeptides for Enhanced Cosmetic Performance |
| P41 | Hilal ATİK ÖZDEN | Simultaneous Quantification of Clobetasol 17-Propionate/Chlorocresol and Impurity Profiling of Clobetasol 17-Propionate in a Fixed Dose Cream Formulation |
| P42 | Kardelen ÖZTÜRK | The Importance of Selecting the Distinguishing Medium in Modified-Release Dosage Forms |
| P43 | Merve BALABAN | Investigation of the in vitro Biological Activities of Ethyl 2-((4,6-Dimethylpyrimidin- 2-yl)amino)acetate |
| P44 | Canay PERÇİN | Development and Validation of an HPLC Method for the Simultaneous Determination of Levamisole and Oxyclozanide in Oral Suspension Formulations |
| P45 | Buse KIZILTAŞ | Synthesis of Indomethacin-Conjugated Biocompatible Triblock Glycopolymer and Investigation of Its Anticancer Effect in the U87-MG |
| P46 | Aygül GONCE | Design and Evaluation of a Dual-API Tablet with Immediate-Release Coating over an Extended-Release Core |
| P47 | Engin ULUKAYA | DLD-6, a Novel Naphthoquinone-Derived Compound, as a Promising Anticancer Candidate for Cholangiocarcinoma |
| P48 | Engin ULUKAYA | A Multi-Stage Drug Repurposing Strategy for Cholangiocarcinoma Treatment |
| P49 | Engin ULUKAYA | Evaluation of a Newly Synthesized Naphthoquinone Derivative as a Potential Anticancer Agent in Cholangiocarcinoma |
| P50 | Furkan KIVANÇ | Comparative Evaluation of Manufacturing Strategies for a Low-Dose Benzydamine Hydrochloride–Cetylpyridinium Chloride Solid Oral Formulation |
| P51 | Ceren PAMUKÇU | From Molecular Attributes to Biosimilarity: A Comparative Study Using SEC, IEX, and CE-SDS |
| P52 | Hasan Hüseyin TOPRAK | Investigation of Strategies to Enhance the Moisture Resistance of Moisture- Sensitive Molecules and Evaluation of Their Impurity Profiles |
| P53 | Önder AKÇA | Development of a Natural, Residue-Free Tablet Formulation to Prevent Varroa- Related Losses in Bee Colonies |
| P54 | Burak İLERİSOY | A Novel, Rapid and High-Sensitivity UPLC Method for Paracetamol Related Substances with Reduced Environmental Impact |
| P55 | Ayla AKINCIOĞLU | Use of bioenhancer lipid excipients in tablets: advantages of Gelucire®48/16 with BCS class II Fenofibrate |
| P56 | Cansu Müşerref YENİCİ | Activity-Based Chemiluminescent Probes for Selective Detection of β-Alanyl Aminopeptidase in Clinically Relevant Bacteria |
| P57 | Özge TOPÇU | A Single HPLC Method for Determination of Methyl/Propyl Paraben and Their Validation in Gentamicin Injection Solution for Veterinary Use |
| P58 | Sibel PARLAYAN | Sustainable Hydrogen Generation Using Jujube-Based Catalysts for Green Pharmaceutical Processes |
| P59 | Şerife Ezgi ÇETİN | Design, Synthesis, and Bioactivity Evaluation of Antimicrobial 2-Substituted Thiazolopyrimidine Compounds |
| P60 | Yusuf ÇİÇEK | Solubility Enhancement of Apixaban via Pamam Dendrimers |
| P61 | Ghazaleh AZİZİ SAADATLOU | All-in-One Multifunctional Nanocarriers for Cancer Therapy |
| P62 | Şura AKÇA | Structure–Activity Insights into Pregnenolone Carbamates as Potent Selective Cholinesterase Inhibitors |
| P63 | Aylin Ece BOZKIR | Determination of Oligo Sequence Accuracy and Impurity Profiles in 3 Separate Brands of QTOF Systems |
| P64 | Bilge TUZCU | Development and Anticancer Assessment of Spirothiazolidinone-Based Compounds |
| P65 | Cemil YERLİ | Development of a Novel RP-HPLC-Fluorescence Method Enabling Highly Sensitive Dissolution Analysis of APIs in Low-Dose Solid Dosage Forms |
| P66 | Fatma Gizem ÇEVİK | A Sensitive and Robust Analytical Procedure for the Cleaning Validation of Dexamethasone Residues |
| P67 | Hacer Ravza UÇAR | Development of Novel Quenchers for Fluorescence-Based Biomolecule Detection and Photosensitizers in Photodynamic Therapy |
| P68 | Şeyda Nur AHRAZ | Synthesis and in silico biological activity evaluation of p-aminophenol – 1,2,3- triazole hybrids |
| P69 | Tolga ÖZBAY | Innovating Ticagrelor Administration via a Clinically Impactful Tablet-to- Nasogastric Tube Approach in Acute Care |
| P70 | Ayşe BAHAROĞLU | An Alternative HPLC Approach to the USP UV Method for Determination of 5- HMF Impurity in Theophylline in Dextrose Injection |
| P71 | Gizem AKPINAR | Synthesis of Novel Indole–Pyrimidine–Triazole Hybrid Molecules |
| P72 | Hacer CEYLAN | Validation of a HPLC Method for Determination of Benzyl Alcohol in Erythromycin Injection Solution for Veterinary Use |
| P73 | Haluk Samet KOÇAK | HOCl-Responsive Type I Phototheranostic Agent and Combination with Elesclomol for Enhanced Therapy and Imaging |
| P74 | Azize YAMAN | Qualitative and Quantitative HPLC–RID Analysis of Sugar Alcohol Excipients for Reverse Engineering of Reference Drug Products |
| P75 | Berk SAVAŞ | Development of an Analytıcal Method as An Alternatıve to Microbiological Assay for Nystatin Quantification |
| P76 | Ceyda ÖZKAN | Rapid Quantification of Diazepam and Benzyl Alcohol in Injection Solutions by RP-HPLC |
| P77 | Serkan SİVRİKAYA | Impurity Evaluation in Pharmaceutical Quality Control: Daily Dose, Threshold, and Rounding Approach |
| P78 | Çağla Nehir ŞİMŞEK | Enhancing In Vivo Predictability for BCS Class II Drugs Using Discriminatory Dissolution Testing with Flow-Through Cell (USP IV) |
| P79 | Şevval DEĞER | Synthesis and Biological Activities of Sulfonylhydrazone Derivatives as New Antibacterial Agents |
| P80 | Fatma Beyza KAFADAR | Exploration of Pyrazole- and Pyrrolidine-Containing Heterocycles for Potential Biological Activity |
| P81 | Ecem TANSIK | Development and Validation of a Stability-Indicating HPLC-DAD Method for the Simultaneous Determination of Levodopa, Benserazide, and Related Impurities in Pharmaceutical Dosage Forms |
| P82 | Lali TCHANKVETADZE | Investigation of Chiral Recognition Mechanisms of Cyclodextrins Using Capillary Electrophoresis and NMR Spectroscopy |
| P83 | Lali TCHANKVETADZE | Isotope-Effect in Capillary Electrophoresis: First Baseline Separation of Isotopomers |
| P84 | Lali TCHANKVETADZE | Synthesis and Chiral Separations of Ibuprofen Derivatives for Increased Anti- Inflammatory Activities |
| P85 | Hacı Mehmet KAYILI | Rapid Glycopeptide-Based Monitoring of Monoclonal Antibody Fc Glycosylation by UHPLC-HILIC-FLD |
| OP1 | Hacı Mehmet KAYILI | HPLC-HILIC-FLD Glycan Signatures with Machine Learning for Early-Stage NSCLC Detection |
| OP2 | Ayşe Hümeyra KAYMAZ | Design and Synthesis of Nitrogen-Containing Hybrid Compounds for EGFR Inhibition |
| OP3 | Havva Berre AYVAZ | A Novel Approach In Acute Myeloid Leukaemia Treatment by Combining Genetic and Epigenetic Candidate Drug Agents |
| OP4 | Eren CANER | Synthesis and Structure Elucidation of 5,7-Diarylsubstituted Triazolopyrimidine Derivatives and Their Anticancer Activities |
| OP5 | Durmuş AKDOĞAN | Highly Sensitive qPCR-based Method Development for Quantitation of Residual Host Cell DNA in Biopharmaceutical Samples |
| OP6 | Derya HATİPOĞLU | Comparative Forced Degradation Stability Assessment for Selecting a New Formulation for a Monoclonal Antibody |
| OP7 | Ramazan KOÇAK | Oxidation of Dihydropyridazines with Trichloroisocyanuric Acid (TCCA) |
| OP8 | Yağız GÜRBÜZER | Development of a High-Performance Liquid Chromatography Method for the Simultaneous Determination of Spiramycin and Metronidazole |
| OP9 | Muhammed Oğuzhan DOĞAN | Synthesis and Structure Elucidation of Some New Hydrazones Bearing Piperidine Ring and Their Derived Metal Complexes |
| OP10 | Setareh DORREH | Molecularly Imprinted Polymer-Based Voltametrıc Sensor For Tenoxicam: An Electrochemical Approach For Antiinflammatory Drug Detection |
| OP11 | Nurettin TOKAY | A Single-Capture SPR Strategy for Quantitative Analysis of Low-Affinity Fc Receptor–Antibody Interactions |
| OP12 | Mustafa Z. KAZANCIOGLU | Design and Synthesis of Urea–Tetrahydroquinoline Hybrid Molecules with Significant Biological Potential |
| OP13 | Ayşe Nur ARSLAN | Combinatorial Anticancer effect of Ethanolic Red Hawthorn Extract and Ethacrynic Acid both on Cholangiocarcinoma and Hepatocellular Carcinoma |
| OP14 | Melek KAYA | Synthesis and Bioactivity Assessment of Novel 2,3-Disubstituted Triazolopyrimidinone Derivatives Targeting NLRP3 Inflammasome Activation |
| OP15 | Hüseyin KOSKER | Synthesis, Structure Elucidation, Anticancer Activities of New 7- Arylmethylamino Triazolopyrimidine Derivatives |
| OP16 | Osman Nuri ASLAN | Synthesis, Characterization and Sensor Applications of a Novel Hydrazone Derivative Molecule |
| OP17 | Ceyhun SARI | A comprehensive in silico approach towards the discovery of Novel Anaplastic Lymphoma Kinase (ALK) Tyrosine Kinase Domain Inhibitors from a Large Natural Product Database |
| OP18 | Merve ÇELİK YAMACI | Analytical-Driven Surfactant Selection in Monoclonal Antibody Formulations: A Comparative LC-CAD Evaluation of Polysorbate 80 and Poloxamer 188 |
| OP19 | Selin BACAKCI | Investigation of the Inhibitory Potential of Astaxanthin on HIV-1 Reverse Transcriptase Using In Silico and In Vitro Approaches |
| OP20 | Sıla GÜLBAĞ PINAR | Development and Evaluation Of New Ibuprofen-Containing Suppository Formulations for Pediatric Purposes |
| OP21 | Şerife Ezgi ÇETİN | Design, Synthesis, and Bioactivity Evaluation of Antimicrobial 2-Substituted Thiazolopyrimidine Compounds |
| OP22 | Büşra UÇAR EKE | Metabolic Profiling of Active and Remission Ulcerative Colitis with Patients |
| OP23 | Ferruh LAFZİ | Ring opening of Donor-acceptor Cyclopropanes via Aminorhodanine |
| OP24 | Fatma BAYRAKÇEKEN NIŞANCI | Electrochemically Engineered C60–Retinol Nanostructured Electrodes: Redox Behavior and Biomedical Applications |
| OP25 | Şüheda ÖZKUL | The investigation of the effect of apricot kernel oil on human erythrocyte carbonic anhydrase isoenzymes (hCA I and hCA II) |
| OP26 | Betül ÇAYIR | Synthesis of New Quinoline-2(1H)-One Derivatives and Determination of Pharmacological Properties |
| OP27 | Dila KUMAS | A Novel Media Screening Strategy for Optimizing the Upstream Mammalian Cell Culture Process |
| OP28 | Duygu ENEŞ | Metabolic Alterations Induced by Momordica charantia L. Extracts in Melanoma Cells |
| OP29 | Jülide KAVUK | Synergistic Antiproliferative Effects of Cinnamic Acid and SYK Inhibition in Cholangiocarcinoma and Hepatocellular Carcinoma Cell Lines |
| OP30 | Melisa TECİK | A novel competing endogenous RNA network based on a RNA-seq reveals potential mechanisms and biomarkers of midostaurin resistance in FLT3-ITD AML |
| OP31 | Rüstem EBİRİ | Synthesis and Biological Activity Evaluation of Chalcone Conjugates Derived from Chiral and Achiral Amino Acids |
| OP32 | Vuslat Hazal ŞAHMETLİOĞLU | Investigation of Therapeutic Intervention of Green Synthesized Silver Zinc Oxide Nanoparticles with Usnea Lichen in the MOLM-13 Cell Line |
| OP33 | Türker DEVECİ | A Study of Dissolution Method Development and Validation for HMN-A1 and HMN-A2 Actıve Substances in Fixed-Dose Combination Tablet Product by HPLC |
| OP34 | Baran DİNGİLOĞLU | Comparative Evaluation of Membrane and Conventional Resin-Based Chromatography Purification in mAbdi2 Biosimilar Downstream Processing |
| OP35 | Oğuzhan DALKILIÇ | Regulatory-Ready LC-MS/MS Determination of Trace-Level N-Nitrosamines in Pharmaceutical Products |
| OP36 | Meryem KAPLAN | Development and In Vitro Characterization of a Soothing Stick Formulation for Dry and Pruritic Skin |
| OP37 | Büşra ÖZTÜRK AYDIN | Synthesis of N-Alkylated Pyrazolo[3,4-d]pyrimidine-Based Chalcone Hybrids |
| OP38 | Amine MUHCU | Experimental and In Silico Evaluation of Satureja spicigera Essential Oil as a Natural Acetylcholinesterase Inhibitor |
| OP39 | Amine Sümeyye KILINÇ | Identification and Characterization of Novel Peptides from Momordica charantia Seeds |
| OP40 | Özlem TUNCER | Synthesis, Characterization, and Determination of Anticancer Activities of Chalcone-Based Gold Nanoparticles |
| OP41 | Arzu GÖBEK | Design, Synthesis, and Evaluation of Novel Hybrid Compounds with Potential Antimicrobial Activity |
| OP42 | Arzu GÖBEK | Chalcone Derivatives as Effective Antibacterial Agents Against Acinetobacter baumannii |
| OP43 | Arzu GÖBEK | Synthesis and Antitubercular Evaluation of Novel Amide-Bridged Bis-Derivative Compounds |
Workshop Programme
| 6 February 2026, Friday | ||
| Antalya I | Antalya II | |
| 10:00-11:00 | Matjaž GOLİČ, MEREL INSTRUMENTS “Dissolution and Laboratory Automation” | Halil İbrahim KIZILARSLAN, Salt Analitik “Analytik Jena TOCnology in Pharmaceutical Cleaning Validation: Approaches and Challenges” |
| 11:00-12:00 | Özlem ÖZTEKİN GÜVEN, Merck İlayda ATAŞ, Merck | Ezgi ÖZLER, ANT TEKNİK “İlaç Endüstrisinde Süperkritik Akışkan Kromatografisi (SFC)” |
| 14:00-15:00 | Xavier MAËS, Agilent Technologies, Altium “OpenLab 2.8 Unique Software Features and Productivity Tools” | |
| 15:00-16:00 | Yunus UZER, IKA “LR 1000 ile Reaktör Teknolojisinde Üst Düzey Kontrol” | |
| 16:00-17:00 | Prof. Dr. Bekir Faruk ERDEN “Farmasötik Ürünlerde Mühendislik” | |
| 7 February 2026, Saturday | ||
| Antalya I | Antalya II | |
10:00-11:00 | Prof. Dr. Engin ULUKAYA “Some practical applications in cancer drug development” | Ali İhsan SEÇKİN, Tetra, Chromax “Peptitlerin İkincil Yapısı ile Kiral Safsızlıkların Tayininde JASCO CD Sistemlerinin Rolü” |
11:00-12:00 | Gözde BAY, Altium Uğur TAN, Altium “The Next Generation of Elemental and Impurity Analysis: Sensitivity, Speed and Intelligence with Agilent Technologies” | Çetin BİCAN, ANT TEKNİK “İlaç Endüstrisinde Katı Dozaj Formu Test Teknolojileri” |
14.00-15:00 | Gamze HATİPOĞLU, IKA “Tablet Öğütmede Yeni Çağ: IKA Patentli Çığır Açan Teknoloji” |
|
15:00-15:30 | Nurten UÇAK, Methrom “Tıtratıon For Pharmaceutıcal Analysıs” | |
15:30-16:30 | A. Begüm BUĞDAYCI, Kobay Deney Hayvanları Laboratuvarı Sanayi ve Ticaret A.Ş. “Bir Kimyasalın Ruhsata Giden Yolculuğu” |
|